Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Genesis IBRC Share Price

Q: What is the Market Capitalization of Genesis IBRC India Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 28 April 2025, the market cap for Genesis IBRC India Ltd. is approximately ₹ 126.1 Cr.

Q: What are the PE and PB ratios for Genesis IBRC India Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Genesis IBRC India Ltd. is -532.7, and the Price-to-Book (PB) ratio is 15.2.

Q: What is the 52-Week High and Low for Genesis IBRC India Ltd.?

Over the past 52 weeks, the highest price reached by Genesis IBRC India Ltd. shares was ₹ 184.9, and the lowest price was ₹ 18.34.

Q: Who are the major shareholders of Genesis IBRC India Ltd.?

Significant shareholdings in Genesis IBRC India Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Genesis IBRC India Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Genesis IBRC India Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Genesis IBRC India Ltd.

₹97

-1.98(-2.00%)

Trade Now

2nd Apr 2026 | 12:33 PM

NSE :

Open Free Demat Account

Genesis IBRC Performance

Price Movement

N/A

₹97.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹97.00

Low₹97.00

Open at₹97.00

Prev Close₹98.98

Volumes17

Avg Price₹97.00

Lower Circuit₹94.04

Upper Circuit₹103.92

Historical Performance

3M High₹108.45

3M Low₹59.43

1 Yr High₹184.90

1 Yr Low₹18.34

3 Yr High₹184.90

3 Yr Low₹9.73

5 Yr High₹184.90

5 Yr Low₹7.46

Genesis IBRC Fundamentals

Market Cap

Below industry Median

126.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-532.70

Dividend Yield

Net Profit TTM

50% decr over last year

-0.24

Net Profit Growth

50% decr over last year

-0.24

PEG Ratio

High in industry

11.60

ROE

154.4% incr over last year

41.07

Operating Revenue TTM

Operating Revenue Growth

Book Value

High in industry

15.20

MFI

MFI strongly Overbought

95.59

RSI

RSI is mid-range

58.47

EPS (TTM)

-0.03

Debt to Equity

Face Value

Operating Profit Margin Qtr.

4.05

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

15.20

Genesis IBRC Financials

Data not available for chart

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0	0	0	0	0
Operating Expense	0.03	0.06	0.12	0.02	0.03
Operating Profit	-0.03	-0.06	-0.12	-0.02	-0.03
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0	0	0	0
Net Profit	-0.03	-0.06	-0.12	-0.02	-0.03

Genesis IBRC Technicals

Genesis IBRC India Ltd. EMA & SMA

₹97.00

-1.98 (-2.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹98.9

Day EMA10 ₹98

Day EMA12 ₹97.1

Day EMA20 ₹93.7

Day EMA26 ₹92

Day EMA50 ₹90.1

Day EMA100 ₹88.4

Day EMA200 ₹75

Genesis IBRC Support and Resistance

Resistance

First Resistance₹97.00

Second Resistance₹97.00

Third Resistance₹97.00

Support

First Support₹97.00

Second Support₹97.00

Third Support₹97.00

Technical Indicators

Day RSI58.47

Day MFI95.59

Day ADX31.56

Day Commodity Channel Index33.80

William-40.81

Day MACD5.17

Day MACD Signal Line4.98

Day ATR4.00

Day ROC12581.34

Day ROC2123.58

Genesis IBRC Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	11.3	11.3	11.3	11.3	11.3	11.3
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	88.7	88.7	88.7	88.7	88.7	88.7

Genesis IBRC Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	10	10	100.00%
Week	21	21	100.00%
1 Month	442	442	100.00%
6 Month	486	486	99.96%

Genesis IBRC SWOT Analysis

Strengths19

Weakness4

Opportunity0

Threats1

Companies with no Debt

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

RSI indicating price strength

Insiders bought stocks

Stocks Outperforming their Industry Price Change in the Quarter

Genesis IBRC Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Genesis IBRC Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹201.95	₹37.60	₹5.80	₹89.80	₹345.05	₹108.50
% Change	-1.49%	1.98%	4.88%	-10.11%	-0.00%	2.54%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	56.00	-95.60	-1.40	11.90	76.40	27.40
1 Year Return		735.56	479	-29.73		-14.23
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.60

-0.42%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.20

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 59.50

+2.06%

APL

Asston Pharmaceuticals Ltd.

₹ 78.00

-1.02%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+0.19%

MEDIORG

Medicamen Organics Ltd.

₹ 23.25

+4.97%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 507.95

+1.69%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 31.79

+4.61%

SENORES

Senores Pharmaceuticals Ltd.

₹ 785.00

+1.48%

INNOVACAP

Innova Captab Ltd.

₹ 703.90

-0.01%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 56.10

-1.48%

SHELTER

Shelter Pharma Ltd.

₹ 29.35

-1.44%

TLL

Trident Lifeline Ltd.

₹ 263.50

-1.03%

DPL

Dipna Pharmachem Ltd.

₹ 9.00

-2.70%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.65

+0.53%

FABINO

Fabino Enterprises Ltd.

₹ 16.73

+4.96%

SUPRIYA

Supriya Lifescience Ltd.

₹ 611.00

+1.66%

SIGACHI

Sigachi Industries Ltd.

₹ 19.45

-0.10%

WINDLAS

Windlas Biotech Ltd.

₹ 766.00

-0.21%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+0.10%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 474.80

+3.42%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+2.27%

FAQ's on GENESIS

What is the Market Capitalization of Genesis IBRC India Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 28 April 2025, the market cap for Genesis IBRC India Ltd. is approximately ₹ 126.1 Cr.

What are the PE and PB ratios for Genesis IBRC India Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Genesis IBRC India Ltd. is -532.7, and the Price-to-Book (PB) ratio is 15.2.

What is the 52-Week High and Low for Genesis IBRC India Ltd.?

Over the past 52 weeks, the highest price reached by Genesis IBRC India Ltd. shares was ₹ 184.9, and the lowest price was ₹ 18.34.

Who are the major shareholders of Genesis IBRC India Ltd.?

Significant shareholdings in Genesis IBRC India Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Genesis IBRC India Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Genesis IBRC India Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy